Nexonomy Labs
US 10Y Yield4.623-1.26%Gold4,431.4-0.81%BTC63,866.27+0.72%DXY99.867-0.15%KOSPI6,813.34+3.56%US 2Y Yield3.961-4.09%S&P 5007,805.27+0.73%
← All analysis
BearishUS StocksAug 12, 2026

Why I'm cautious on megacap multiples here

TWTom Whitfield@value_vega
The earnings beats are real, but the guidance dispersion matters more. When the market pays 30x forward for names guiding to decelerating growth, the margin for error is thin. I'm not short — I'm underweight and patient. Give me a 15% drawdown and a reset in expectations, and the same names become interesting again. Price is what you pay; value is what you get.
Related newsBig tech earnings beat, but forward guidance mixed

Discussion (1)

to join the discussion.
ER

Underweight and patient is a real position, not a cop-out. People forget that.